19 February 2018
News and Views
Links and Services
This week's issue of New England Journal of Medicine compares peginterferon alfa-2b or alfa-2a with ribavirin for treatment of Hep C infection.
Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combi
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors